2022
DOI: 10.1016/j.cmet.2022.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
108
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 172 publications
(108 citation statements)
references
References 44 publications
0
108
0
Order By: Relevance
“…The first step of glycolysis is catalyzed by hexokinase (HK), which converts glucose to glucose-6-phosphate (G-6-P). Recent studies have shown that HK2 can promote tumour immune evasion by phosphorylating IκBα, leading to the degradation of IκBα, activation of the NF-κB signalling pathway, and elevated PD-L1 expression levels [ 26 ]. We showed that CSFV infection inhibits the rate of extracellular acidification and reduces the overall cellular glycolysis level.…”
Section: Resultsmentioning
confidence: 99%
“…The first step of glycolysis is catalyzed by hexokinase (HK), which converts glucose to glucose-6-phosphate (G-6-P). Recent studies have shown that HK2 can promote tumour immune evasion by phosphorylating IκBα, leading to the degradation of IκBα, activation of the NF-κB signalling pathway, and elevated PD-L1 expression levels [ 26 ]. We showed that CSFV infection inhibits the rate of extracellular acidification and reduces the overall cellular glycolysis level.…”
Section: Resultsmentioning
confidence: 99%
“…Recent studies demonstrated that increased lactic acid in the TME could suppress anticancer immune cells by disturbing their intracellular pH ( Frauwirth et al, 2002 ; Gottfried et al, 2006 ) and impair T cell proliferation and cytokine production ( Brand et al, 2016 ; Fischer et al, 2007 ). Furthermore, Guo et al (2022) revealed that tumor immune evasion can be directly regulated by availability of glucose in the TME. When cancer glycolytic activity competes with immune cells for glucose uptake ( Husain et al, 2013a ; Husain, Seth & Sukhatme, 2013b ), cancer cells could effectively achieve immune evasion.…”
Section: Discussionmentioning
confidence: 99%
“…In ovarian cancer, Tregs pretreated with 2-DG also alleviate the inhibition of effector T cell proliferation ( Xu et al, 2021b ). In addition, HK recently has been found to upregulate PD-L1 expression in cancer cells in an NF-κB-dependent pathway, and HK inhibitor Lonidamine has shown favorable cancer elimination in combination with anti-PD-1 therapy in mice model ( Guo et al, 2022 ). However, the severe systemic toxicity induced by HK inhibitors in clinical studies warrants further investigation ( Pouysségur et al, 2022 ).…”
Section: Available Glycolysis-targeted Therapiesmentioning
confidence: 99%